![](/img/cover-not-exists.png)
Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure: The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators
P.H.J.M DunselmanVolume:
77
Year:
2001
Language:
english
DOI:
10.1016/s0167-5273(00)00426-5
File:
PDF, 85 KB
english, 2001